openPR Logo
Press release

2020-2025 Acute Bronchitis Treatment Market to witness astonishing growth with Top Key Players - Sanofi, AstraZeneca, Boehringer Ingelheim, GSK, Novartis, Dr Reddy's Lab

05-13-2020 05:28 AM CET | Health & Medicine

Press release from: Business Industry Reports

Acute Bronchitis Treatment Market

Acute Bronchitis Treatment Market

All information provided in the report is derived from trusted industrial sources. Global Acute Bronchitis Treatment Market research reports finds market figures between 2020 and 2025. The market will exhibit remarkable CAGRs in the aforementioned period.

Overview of Global Acute Bronchitis Treatment Market:

This report studies the Global Acute Bronchitis Treatment Market over the forecast period of 2020 to 2025. The Global Acute Bronchitis Treatment Market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) from 2020 to 2025.

Significant key factors driving the growth of the Global Acute Bronchitis Treatment Market are rapid growth in the geriatric population with increased prevalence of bronchitis, increase in habits like smoking and increased levels of chemical pollutants. As per the CDC (Centres for Disease Control and Prevention) in the year 2018, 9.0 million adults got diagnosed with chronic bronchitis. Also, the recent report from COPD foundation.org smoking is associated with 90 percent of all COPD deaths in the United States. However patent expiry of the key drugs is a constraint to the growth of the market.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/254001 .

The Global Acute Bronchitis Treatment Market is segmented on the basis of Type, Application and Region. Based on the Type, the Global Acute Bronchitis Treatment Market is sub-segmented into Antibiotics, Anti-inflammatory Drugs, Bronchodilator, Mucolytic and others. On the basis of Application, the Global Acute Bronchitis Treatment Market is classified into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and others.

In terms of the geographic analysis, The Acute Bronchitis Treatment Market in North America is expected to grow at the highest CAGR during the forecast period. Moreover, the presence of major players in the Acute Bronchitis Treatment Market ecosystem results in the increasing adoption of these systems in North America.

Global Acute Bronchitis Treatment Market Objectives:

1 To provide detailed information regarding key factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the Acute Bronchitis Treatment Market

2 To analyze and forecast the size of the Acute Bronchitis Treatment Market, in terms of value and volume

3 To analyze opportunities in the Acute Bronchitis Treatment Market for stakeholders and provide a competitive landscape of the market

4 To define, segment, and estimate the Acute Bronchitis Treatment Market based on deposit type and end-use industry

5 To strategically profile key players and comprehensively analyze their market shares and core competencies

6 To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market

7 To forecast the size of market segments, in terms of value, with respect to main regions, namely, Asia Pacific, North America, Europe, the Middle East & Africa, and South America

8 To track and analyze competitive developments, such as new product developments, acquisitions, expansions, partnerships, and collaborations in the Acute Bronchitis Treatment Market

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Global Acute Bronchitis Treatment Market Report 2020" @ https://www.businessindustryreports.com/buy-now/254001/single .

Top Leading Key Manufacturers are: AstraZeneca, Boehringer Ingelheim, GSK, Novartis, Melinta Therapeutics, Dr Reddy's Laboratories, Sanofi and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Global Medical Industry News:

Sanofi (May 05, 2020) - Libtayo (cemiplimab) shows clinically meaningful and durable responses in second-line advanced basal cell carcinoma - Topline data for a pivotal, single-arm, open-label trial for Sanofi and Regeneron's PD-1 inhibitor Libtayo (cemiplimab) in patients with advanced basal cell carcinoma (BCC) who had progressed on or were intolerant to prior hedgehog pathway inhibitor (HHI) therapy were announced today. Libtayo demonstrated clinically meaningful and durable responses in this group of patients for whom there are no approved treatments. Sanofi and Regeneron plan regulatory submissions in 2020.

BCC is a skin cancer and is the most common cancer worldwide, with approximately two million new cases diagnosed every year in the U.S. alone. While the vast majority of BCCs are caught early and cured with surgery or radiation, a small proportion of tumors can become advanced and penetrate deeper into surrounding tissues (locally advanced), which is more difficult to treat. Approximately 20,000 U.S. patients have advanced BCC and it is estimated that about 3,000 die each year. BCC marks the second non-melanoma skin cancer for which Libtayo has demonstrated first-in-class data and follows its initial U.S. approval in advanced cutaneous squamous cell carcinoma (CSCC) in 2018.

In the trial, the objective response rate (ORR) for patients (n=84) with locally advanced disease was 29% (95% CI: 19%-40%), with an estimated duration of response (DOR) exceeding one year in 85% of responders. The durable disease control rate (DCR --response or stable disease lasting at least 6 months) was 60% (95% CI: 48%-70%). In a preliminary analysis of patients (n=28) with metastatic disease, the ORR was 21% (95% CI: 8%-41%), with an estimated DOR exceeding one year in 83% of responders. The durable DCR was 46% (95% CI: 28%-66%). All data were assessed by an independent central review. Data are expected to continue to evolve with further follow-up across both patient groups.

"While PD-1 inhibitors have transformed the outlook for many patients with melanoma, progress for patients with non-melanoma skin cancers has not been as rapid," said Peter C. Adamson, M.D, Global Head of Oncology Development at Sanofi. "We are continuing to address this unmet need by first bringing Libtayo to patients with advanced cutaneous squamous cell carcinoma, and now, with this second trial, as a potential therapy for patients with advanced basal cell carcinoma. These important new results further demonstrate Libtayo's potential in patients with difficult-to-treat, non-melanoma skin cancers."

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Acute Bronchitis Treatment in these regions, from 2013 to 2025 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/254001 .

Major Points in Table of Contents:

Global Acute Bronchitis Treatment Market Report 2020

1 Acute Bronchitis Treatment Product Definition

2 Global Acute Bronchitis Treatment Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Acute Bronchitis Treatment Shipments

2.2 Global Manufacturer Acute Bronchitis Treatment Business Revenue

2.3 Global Acute Bronchitis Treatment Market Overview

3 Manufacturer Acute Bronchitis Treatment Business Introduction

3.1 AstraZeneca Acute Bronchitis Treatment Business Introduction

3.2 Boehringer Ingelheim International Acute Bronchitis Treatment Business Introduction

3.3 GlaxoSmithKline Acute Bronchitis Treatment Business Introduction

3.4 Novartis AG Acute Bronchitis Treatment Business Introduction

3.5 Melinta Therapeutics Acute Bronchitis Treatment Business Introduction

3.6 Dr Reddy's Laboratories Acute Bronchitis Treatment Business Introduction

................... Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2020-2025 Acute Bronchitis Treatment Market to witness astonishing growth with Top Key Players - Sanofi, AstraZeneca, Boehringer Ingelheim, GSK, Novartis, Dr Reddy's Lab here

News-ID: 2043291 • Views:

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo International, Nuvo Pharma, Ferndale Pharma, Galen, Jazz Pharma, Paladin Labs, St Renatus, MSK Pharma
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (Lockheed Martin, BAE System, Boeing, General Dynamic, Raytheon) | Forecast to 2025
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growth by Top Key Company’s - J&J, Medtronic, B Braun, Boston Medical, Integra, Stryker, Zimmer, CONMED
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key Players - Apple, Fitbit, Synbiota, THE ODIN, HVMN, Thync Global, Moodmetric
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Acute

Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but
Pipeline Review, H2 2017 of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic …
"Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '
Acute Renal Failure (ARF) (Acute Kidney Injury) Market: Industry Size, Share, Gr …
Latest industry research report on: Acute Renal Failure (ARF) (Acute Kidney Injury) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2017, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Request For Sample Report
Acute Renal Failure (ARF) (Acute Kidney Injury) Pipeline Review, H2
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2017” to its report offerings. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1230595 Acute kidney failure occurs when kidneys suddenly become unable to filter waste products from blood.
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth